FROM Kevin Sullivan
Foreign Investor Program Offers Green Cards for Cash It's an immigration program for the rich. The EB-5 program allows up to 10,000 people a year to immigrate to the US in exchange for an investment of at least $500,000 in an American business. If the investment helps create ten jobs, the investor becomes eligible for permanent residency. Last year, more than seven-thousand people used the program. Kevin Sullivan, senior correspondent for the Washington Post , explains.
More Reports of Violent Clashes in Iran There are reports today of more bloody repression on the streets of Tehran. In a cell-phone conversation, a 20-something student told CNN's Ivan Watson that "security forces are shooting on people…this was a massacre…they were beating people so they would die…you should stop this, you should help the people of Iran who demand freedom." Kevin Sullivan is the foreign editor of the Washington Post .
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.
What is Trump's plan for Middle East peace? On his first foreign tour, President Trump has promised "peace" between Israel and the Palestinians. Are there any details for re-starting talks that have been stalled for the past three years?
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.